Market research
SINT SINTX Technologies Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 10M
- P/E ratio
- Not available
- Analyst target
- 9.125
- Dividend yield
- Not available
- Beta
- 0.64
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US8293927039
- Market cap
- 10M
- P/E ratio
- Not available
- Analyst target
- 9.125
- Dividend yield
- Not available
- Beta
- 0.64
About
About SINTX Technologies Inc
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the SINT discussion.
5 years, 4 months ago
Sintx Technologies, Inc is currently in a long term downtrend where the price is trading 9.0% below its 200 day moving average.
From a valuation standpoint, the stock is 96.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 54.0.
Sintx Technologies, Inc's total revenue sank by 53.6% to $117K since the same quarter in the previous year.
Its net income has increased by 99.8% to $-2K since the same quarter in the previous year.
Finally, its free cash flow fell by 6.9% to $-2M since the same quarter in the previous year.
Based on the above factors, Sintx Technologies, Inc gets an overall score of 2/5.